Centella FIPC
A novel, optimized-absorption active from Centella asiatica (Gotu Kola), engineered for wound-healing and skin-barrier repair and collagen stimulation in cosmeceutical formulation. Arceli is an India-based manufacturer built around supercritical CO₂ (SCFE) extraction, supplying standardized botanical actives to formulators worldwide.
// Key advantages
// Specification
- Botanical name
- Centella asiatica
- Standardization
- Optimized Absorption Complex
- Dose
- Application-dependent — see technical dossier
Full certificate of analysis and technical dossier available on request.
// Sourcing & Manufacturing
Centella FIPC is manufactured at Arceli's own 300L facility in Dehradun (Selaqui), Uttarakhand — the same GMP, FSSAI, ISO 9001, ISO 22000, and FSSC 22000-certified site that produces every ingredient in the ArcoPure™ line. Available as a standardized branded ingredient for direct purchase, or as the base for private-label and custom-specification manufacturing.
// Mechanism
Formulated for optimized absorption relative to standard Centella asiatica extracts, via ArcoPure™ purification.
// Benefits
- Wound-healing and skin-barrier repair support
- Anti-aging via collagen stimulation
// Key research
Supported by published reviews and dermal-fibroblast research on the Centella triterpene fraction — asiaticoside and madecassoside — covering type I and type III collagen synthesis and wound-healing applications. These claims describe the standardised triterpene fraction characterised in that literature, not Centella extract generally.
- 01Postepy Dermatologii i Alergologii - Centella asiatica in cosmetology (Bylka, W. et al.)Reviews Centella asiatica in cosmetology, treating the triterpene fraction — not the whole herb — as the active principle in cosmetic use.
- 02Phytotherapy Research - Centella asiatica in dermatology: an overview (Bylka, W. et al.)Dermatological overview of Centella asiatica, covering the asiaticoside and madecassoside fraction across skin applications.
- 03Madecassoside and asiaticoside - collagen I and III synthesis in human dermal fibroblastsMadecassoside and asiaticoside are associated with increased synthesis of type I and type III collagen in human dermal fibroblasts, via TGF-β/Smad signalling — the basis for the collagen-stimulation positioning.
- 04Titrated extract of Centella asiatica (TECA) - wound healing and repair reviewTitrated extract of Centella asiatica (TECA), a standardised preparation of asiaticoside, asiatic acid and madecassic acid, studied in wound-healing and repair contexts — the basis for the wound-healing and barrier-repair framing.
Citations refer to published literature on these compounds generally, not to clinical trials of Arceli's specific extract unless otherwise noted. Full dossier available on request.
// Frequently asked
What is Centella FIPC standardized to?
Centella FIPC is standardized to Optimized Absorption Complex, verified on every batch using validated analytical methods and powered by Arceli's ArcoPure™ purification platform.
Is Centella FIPC patent-pending?
Yes — Centella FIPC is produced using Arceli's ArcoPure™ technology, covered by a provisional patent application (public record).
What industries use Centella FIPC?
Centella FIPC is formulated for Cosmeceuticals.
What is the typical dose for Centella FIPC?
Application-dependent — see technical dossier. Application-specific dosing should be confirmed against the full technical dossier.
What botanical source is Centella FIPC derived from?
Centella FIPC is derived from Centella asiatica.
// Further reading
Arceli Lifescience